Retractable Technologies, Inc. (RVP)
| Market Cap | 301.77M |
| Revenue (ttm) | 81.86M |
| Net Income (ttm) | 26.62M |
| Shares Out | 33.98M |
| EPS (ttm) | 0.80 |
| PE Ratio | 11.44 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 13 |
| Last Price | $9.15 |
| Previous Close | $8.88 |
| Change ($) | 0.27 |
| Change (%) | 3.04% |
| Day's Open | 9.00 |
| Day's Range | 8.89 - 9.37 |
| Day's Volume | 322,515 |
| 52-Week Range | 4.18 - 21.50 |
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announced today that, in accordance with the 30 day notice requirement, it received a preliminary notice from the ...
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B Convertible...
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2020. Further details concerning the res...
Retractable Technologies saw its IBD SmartSelect Composite Rating jump to 96 Thursday, up from 94 the day before. The post Retractable Technologies Receives IBD Stock Rating Upgrade appeared first on In...
He's a stickler for predictable and recurring revenue.
Investing in the recovery from the pandemic could pay off big.
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series I Class B and Series I...
These companies made millions by developing equipment for life-saving care, and enriched shareholders too.
These stocks have made investors richer by posting explosive revenue growth or advancing significantly in high-impact programs.
Sales jumped 132% in the most recent quarter, as demand for the company's syringes have skyrocketed.
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $10.3 million in the third quarter of 2020, compared to an operating income ...
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series I Class B and Series I...
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $960 thousand in the second quarter of 2020, compared to an operating income...
The company's been awarded a multimillion-dollar government COVID-19 contract to expand production of needles and syringes.
Retractable Technologies Inc. reported Q1 earnings highlighted by strong sales growth and firming profitability.
Retractable Technologies (NYSE: RVP) shares are trading higher on Monday, after a report the company has won a government contract for $84 million.
About RVP
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holder; allergy tray; IV safety catheter; Patient Safe syringes and Luer Caps; VanishPoint blood collection set; EasyPoint needles; and VanishPoint autodisable syringes. The company di... [Read more...]
| Industry Medical Instruments & Supplies | IPO Date May 4, 2001 |
| Stock Exchange NYSEAMERICAN | Ticker Symbol RVP |
Financial Performance
In 2020, RVP's revenue was $81.86 million, an increase of 95.86% compared to the previous year's $41.80 million. Earnings were $24.22 million, an increase of 669.42%.